Eikonic is an award winning, Australian based start-up, on a global mission to help people retain their teeth for life, through the development of its proprietary technology - a nano-coating designed to protect teeth and gums from bacteria to dramatically reduce gum disease and tooth decay which generate a growing and significant social and economic burden on citizens; and private and public healthcare budgets worldwide
As a social enterprise, with a tripartite purpose focused on the 3Ps: People, Planet and Profits, EIKONIC has a social mission to restore oral health for people and society by reorienting modern dentistry from focusing on treatment to focusing on prevention.
US$442 billion per year is the estimated total global cost of dental diseases (direct US$298 billion & indirect cost US$144 billion). The global burden of gum diseases remains high with US $54 billion per year in lost productivity.
Gum disease affects more than 70% of the global population and incidence increases with age.
If left untreated, gum disease can lead to tooth loss, which may cause physical, social and psychological disabilities.
Gum disease is associated with some of the world’s most chronic diseases eg. diabetes, heart disease and arthritis. There can be adverse pregnancy outcomes for women.
The most recent Global Burden of Disease Study (2010) indicates severe gum disease is the 6th most prevalent disease worldwide and the global burden of gum disease increased by 57.3%.
International research demonstrates that by preventing/treating gum disease, it can provide significant reductions in medical and dental care costs globally.
Over time, EIKONIC intends to apply its proprietary technologies across a range of other industries. This will not only result in a better quality of life for people afflicted with chronic non-communicable disease but also will create significant social value for humankind by helping modern medicine transition from the management and treatment of disease symptoms to discovering preventives and cures for disease itself and thereby reduce the healthcare burdens for governments worldwide.